Tissue-glue injection into the pancreas during pancreaticoduodenectomy
Official title: Efficacy of Pancreatic Parenchymal N-Butyl-2-Cyanoacrylate Injection in Pancreaticojejunostomy After Pancreaticoduodenectomy: A Randomized Controlled Trial
Run by Minia University · NCT07230509 · Data updated 2026-11-12
This trial will test whether injecting a tissue glue called N-butyl-2-cyanoacrylate into the pancreatic remnant during pancreaticoduodenectomy reduces postoperative pancreatic fistulas in patients with a soft pancreas and a small main duct.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 90 (estimated) |
| Sponsor | Minia University Academic / other |
| Locations | 1 site (Minya, Minya Governorate) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | December 1, 2027 |
| Study ends | December 20, 2027 |
| Registry record updated | December 2, 2025 |
| Trial ID | NCT07230509 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients undergoing pancreaticoduodenectomy with curative intent for pancreatic or periampullary cancers who have a soft pancreas, a main pancreatic duct under 3 mm, and are medically fit to consent and undergo surgery.
✕Probably not a fit
Patients with a hard fibrotic pancreas, large ducts, active pancreatic remnant pancreatitis, distant metastases, vascular invasion requiring resection, or those unfit for surgery are unlikely to benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized controlled phase 2 trial that will enroll about 90 patients undergoing pancreaticoduodenectomy for malignant disease and randomly assign them to receive pancreatic parenchymal injection of N-butyl-2-cyanoacrylate (NBCA) or standard pancreaticojejunostomy alone. The primary outcome is the incidence of postoperative pancreatic fistula (POPF) using ISGPS definitions, with secondary outcomes including length of hospital stay, readmission, reoperation, mortality, and other postoperative complications. The intervention uses NBCA, a tissue adhesive with hemostatic and sealing properties, delivered into the pancreatic parenchyma during the anastomosis. The trial is single-center at Minia University and targets patients with soft pancreatic texture and a main duct diameter under 3 mm.
Why it matters
Potential benefit: If successful, this technique could lower rates of postoperative pancreatic fistula, shorten hospital stays, and reduce reoperations and other complications.
How similar studies have gone: NBCA and other tissue adhesives have been used successfully in various surgical settings and small case series suggest potential benefit for sealing pancreatic tissue, but randomized controlled evidence specifically in pancreaticoduodenectomy is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients undergoing pancreaticoduodenectomy for malignant lesions meeting the curative treatment intent in accordance with clinical guidelines. * Soft pancreatic texture. * Small main pancreatic duct diameter (\<3 mm). * Informed consent obtained. Exclusion Criteria: * Known hypersensitivity to cyanoacrylate or Lipiodol®. * Extremely hard, fibrotic pancreas. * Significant pancreatitis involving the pancreatic remnant. * Active infection at the surgical site. * Uncontrolled coagulopathy. * Unfit patients for surgery due to severe medical illness. * Inoperable patients with distant metastases, including peritoneal, liver, distant lymph node metastases, and involvement of other organs. * Irresectable tumors in diagnostic laparoscopy. * Patients requiring left, central or total pancreatectomy or other palliative surgery. * Pregnant or breastfeeding women. * Patients with serious mental disorders. * Patients with vascular invasion and requiring vascular resection. * Patients refused to participate in the study.
Where it's running
-
Liver and GIT hospital , Minia University
Minya, Minya Governorate, Egypt Recruiting
Study contacts
- Principal investigator: Saleh K Saleh, MD — Minia University
- Study coordinator: Saleh K Saleh, MD
- Email: salehkhairy@mu.edu.eg
- Phone: 01201765401
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Saleh's technique: injecting Histoacryl glue into the pancreas during pancreaticojejunostomy
This procedure will try injecting a tissue glue (Histoacryl) into the pancreas during pancreaticoduodenectomy to see if it reduces pancreatic leaks in people with a soft pancreas and a small pancreatic duct.
-
Neoadjuvant chemotherapy versus immediate surgery for resectable pancreatic head and periampullary cancer
This trial tests if giving chemotherapy before surgery helps people with resectable pancreatic head or periampullary cancer live longer than having immediate surgery followed by chemotherapy.
-
Predicting pancreatic fistula after pancreaticoduodenectomy
This project will try to find which before-, during-, and after-surgery factors predict clinically significant pancreatic fistula in adults having pancreaticoduodenectomy for pancreatic or periampullary tumors.
-
Surgery with Islet Autotransplantation for Patients with Pancreatic Cancer
This study is testing if a surgery that includes removing the whole pancreas and transplanting the patient's own insulin-producing cells can help people with pancreatic cancer avoid complications and start treatment faster compared to just removing part of the pancreas.
-
Analyzing factors affecting pancreatic tumors and cysts
This study looks at how different factors affect pancreatic tumors and cysts to help improve treatment options for patients.
-
Local complications of acute pancreatitis and postoperative pancreatic fistula: what happens in real life
This multicenter registry tests how local pancreatic complications are managed in routine care and what outcomes look like over 180 days for adults.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.